FDAnews Drug Daily Bulletin

SENTRX RECEIVES ADDITIONAL INVESTMENT

June 9, 2006
A A

Sentrx, the leading provider of drug safety services, announced today that it closed a new round of financing. The investment will be used to enhance information technology, increase sales and marketing activities, and expand client support. The financing was led by Argosy Partners, a new investor for Sentrx. Argosy Partners is a leading source of growth capital for middle market manufacturing and service companies.
Emediawire